Back to Market Feed

DARIFENACIN ER 7.5 MG TABLET

Darifenacin Hydrobromide
$0.5767per EA

Strength

7.5 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097043102

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DARIFENACIN HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207664

On Market Since

9/1/2016

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price History

1W

0.0%

1M

-11.1%

3M

-13.7%

6M

-3.8%

1Y

-3.8%

3Y

-62.7%

5Y

-78.2%

All

-92.6%

Generic Alternatives

1 alternative • Same active ingredient

DARIFENACIN ER 7.5 MG TABLET
Generic
69097043105•Cipla USA Inc.
$0.5767

Related Drugs

Same classification

OXYBUTYNIN 5 MG/5 ML SYRUP
Generic
54838051080•Lannett Company Inc.
$0.0321
per ML
OXYBUTYNIN 5 MG/5 ML SOLUTION
Generic
62135052047•Chartwell RX LLC
$0.0321
per ML
OXYBUTYNIN 5 MG TABLET
Generic
64380078108•Strides Pharma Inc.
$0.0468
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003800•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003801•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003810•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003850•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00904702761•Major Pharmaceuticals
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020101•KVK-Tech Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020110•KVK-Tech Inc.
$0.0484
per EA